Sickle cell disease (English Wikipedia)

"Parvovirus B19 | CDC". www.cdc.gov. 24 August 2023. Retrieved 8 May 2024.
"Data & Statistics on Sickle Cell Disease | CDC". Centers for Disease Control and Prevention. 31 August 2016. Retrieved 13 December 2019.
"September is Sickle Cell Awareness Month". CDC. Archived from the original on 27 September 2010. Retrieved 6 February 2011.

clevelandclinic.org

my.clevelandclinic.org

"Sickle Cell Anemia: Symptoms, What It Is, Causes & Treatment". Cleveland Clinic. Retrieved 8 May 2024.

clinchem.org

Clarke GM, Higgins TN (August 2000). "Laboratory investigation of hemoglobinopathies and thalassemias: review and update". Clinical Chemistry. 46 (8 Pt 2): 1284–1290. doi:10.1093/clinchem/46.8.1284. PMID 10926923. Archived from the original on 20 March 2008.

clinicaltrials.gov

Clinical trial number NCT02247843 for "Stem Cell Gene Therapy for Sickle Cell Disease" at ClinicalTrials.gov
Clinical trial number NCT00012545 for "Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease" at ClinicalTrials.gov

doi.org

Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Nelson MD, Bennett DM, Lehman ME, Okonji AI (5 December 2022). "Dizziness, Falls, and Hearing Loss in Adults Living With Sickle Cell Disease". American Journal of Audiology. 31 (4): 1178–1190. doi:10.1044/2022_AJA-22-00059. ISSN 1558-9137. PMID 36251873.
Wilkinson E (16 November 2023). "UK regulator approves "groundbreaking" gene treatment for sickle cell and β thalassaemia". BMJ. 383: 2706. doi:10.1136/bmj.p2706. ISSN 1756-1833. PMID 37973171. S2CID 265264939.
Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (Global Burden of Disease Study 2013 Collaborators) (August 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 386 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472.
Rees DC, Williams TN, Gladwin MT (December 2010). "Sickle-cell disease". Lancet. 376 (9757): 2018–2031. doi:10.1016/s0140-6736(10)61029-x. PMID 21131035. S2CID 29909566.
Savitt TL, Goldberg MF (January 1989). "Herrick's 1910 case report of sickle cell anemia. The rest of the story". The Journal of the American Medical Association. 261 (2): 266–271. doi:10.1001/jama.261.2.266. PMID 2642320.
Serjeant GR (December 2010). "One hundred years of sickle cell disease". British Journal of Haematology. 151 (5): 425–429. doi:10.1111/j.1365-2141.2010.08419.x. PMID 20955412.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. (September 2014). "Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members". The Journal of the American Medical Association. 312 (10): 1033–1048. doi:10.1001/jama.2014.10517. PMID 25203083. S2CID 37681044.
Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. (15 July 1995). "Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease [see comments]". Blood. 86 (2): 776–783. doi:10.1182/blood.v86.2.776.bloodjournal862776. ISSN 0006-4971.
Olujohungbe A, Burnett AL (March 2013). "How I manage priapism due to sickle cell disease". British Journal of Haematology. 160 (6): 754–765. doi:10.1111/bjh.12199. PMID 23293942.
Anie KA, Green J (May 2015). "Psychological therapies for sickle cell disease and pain". The Cochrane Database of Systematic Reviews. 2015 (5): CD001916. doi:10.1002/14651858.CD001916.pub3. PMC 7063720. PMID 25966336.
Pearson HA (August 1977). "Sickle cell anemia and severe infections due to encapsulated bacteria" (Free full text). The Journal of Infectious Diseases. 136 (Suppl): S25–S30. doi:10.1093/infdis/136.Supplement.S25. PMID 330779. Archived from the original on 27 May 2016.
Wong WY, Powars DR, Chan L, Hiti A, Johnson C, Overturf G (March 1992). "Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience". American Journal of Hematology. 39 (3): 176–182. doi:10.1002/ajh.2830390305. PMID 1546714. S2CID 19977178.
Khatib R, Rabah R, Sarnaik SA (January 2009). "The spleen in the sickling disorders: an update". Pediatric Radiology. 39 (1): 17–22. doi:10.1007/s00247-008-1049-9. PMID 19002450. S2CID 2547649.
Mekontso Dessap A, Leon R, Habibi A, Nzouakou R, Roudot-Thoraval F, Adnot S, et al. (March 2008). "Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease". American Journal of Respiratory and Critical Care Medicine. 177 (6): 646–653. CiteSeerX 10.1.1.504.790. doi:10.1164/rccm.200710-1606OC. PMID 18174543.
Paul RN, Castro OL, Aggarwal A, Oneal PA (September 2011). "Acute chest syndrome: sickle cell disease". European Journal of Haematology. 87 (3): 191–207. doi:10.1111/j.1600-0609.2011.01647.x. PMID 21615795. S2CID 40320701.
Sysol JR, Machado R (2016). "Sickle Cell Disease and Acute Chest Syndrome: Epidemiology, Diagnosis, Management, Outcomes". Hematologic Abnormalities and Acute Lung Syndromes. Respiratory Medicine. pp. 67–87. doi:10.1007/978-3-319-41912-1_4. ISBN 978-3-319-41910-7. PMC 7120070.
Slavov SN, Kashima S, Pinto AC, Covas DT (August 2011). "Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions". FEMS Immunology and Medical Microbiology. 62 (3): 247–262. doi:10.1111/j.1574-695X.2011.00819.x. PMID 21585562.
Balgir RS (March 2012). "Community expansion and gene geography of sickle cell trait and G6PD deficiency, and natural selection against malaria: experience from tribal land of India". Cardiovascular & Hematological Agents in Medicinal Chemistry. 10 (1): 3–13. doi:10.2174/187152512799201190. PMID 22264009.
Fibach E, Rachmilewitz E (2008). "The Role of Oxidative Stress in Hemolytic Anemia". Current Molecular Medicine. 8 (7): 609–619. doi:10.2174/156652408786241384. PMID 18991647.
Worrall VT, Butera V (December 1976). "Sickle-cell dactylitis". The Journal of Bone and Joint Surgery. American Volume. 58 (8): 1161–1163. doi:10.2106/00004623-197658080-00024. PMID 1002763. Archived from the original on 23 September 2016.
Miller ST (May 2011). "How I treat acute chest syndrome in children with sickle cell disease". Blood. 117 (20): 5297–5305. doi:10.1182/blood-2010-11-261834. PMID 21406723. S2CID 206896811.
Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ (December 2011). "Management of children with sickle cell disease: a comprehensive review of the literature". Pediatrics. 128 (6): e1552–e1574. doi:10.1542/peds.2010-3686. PMID 22123880. S2CID 14524078. Archived from the original on 4 March 2016.
Adams RJ, Ohene-Frempong K, Wang W (2001). "Sickle cell and the brain". Hematology. American Society of Hematology. Education Program. 2001 (1): 31–46. doi:10.1182/asheducation-2001.1.31. PMID 11722977.
Adams RJ (November 2007). "Big strokes in small persons". Archives of Neurology. 64 (11): 1567–1574. doi:10.1001/archneur.64.11.1567. PMID 17998439.
Martí-Carvajal AJ, Solà I, Agreda-Pérez LH (December 2019). "Treatment for avascular necrosis of bone in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 2019 (12): CD004344. doi:10.1002/14651858.CD004344.pub7. PMC 6894369. PMID 31803937.
Kenny MW, George AJ, Stuart J (July 1980). "Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism". Journal of Clinical Pathology. 33 (7): 622–625. doi:10.1136/jcp.33.7.622. PMC 1146172. PMID 7430367.
Chrouser KL, Ajiboye OB, Oyetunji TA, Chang DC (April 2011). "Priapism in the United States: the changing role of sickle cell disease". American Journal of Surgery. 201 (4): 468–474. doi:10.1016/j.amjsurg.2010.03.017. PMID 21421100.
Almeida A, Roberts I (May 2005). "Bone involvement in sickle cell disease". British Journal of Haematology. 129 (4): 482–490. doi:10.1111/j.1365-2141.2005.05476.x. PMID 15877730. S2CID 908481.
Elagouz M, Jyothi S, Gupta B, Sivaprasad S (July 2010). "Sickle cell disease and the eye: old and new concepts". Survey of Ophthalmology. 55 (4): 359–377. doi:10.1016/j.survophthal.2009.11.004. PMID 20452638.
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. (January 2008). "Daily assessment of pain in adults with sickle cell disease". Annals of Internal Medicine. 148 (2): 94–101. CiteSeerX 10.1.1.690.5870. doi:10.7326/0003-4819-148-2-200801150-00004. PMID 18195334. S2CID 34924760.
Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT (June 2014). "Pulmonary arterial hypertension: the clinical syndrome". Circulation Research. 115 (1): 115–130. doi:10.1161/CIRCRESAHA.115.301146. PMC 4096686. PMID 24951762.
Caughey MC, Poole C, Ataga KI, Hinderliter AL (August 2015). "Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review". British Journal of Haematology. 170 (3): 416–424. doi:10.1111/bjh.13447. PMID 25854714. S2CID 23920740.
Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, et al. (March 2016). "Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease". JACC. Cardiovascular Imaging. 9 (3): 243–252. doi:10.1016/j.jcmg.2015.05.013. PMC 4788530. PMID 26897687.
Niss O, Fleck R, Makue F, Alsaied T, Desai P, Towbin JA, et al. (July 2017). "Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia". Blood. 130 (2): 205–213. doi:10.1182/blood-2017-02-767624. PMC 5510791. PMID 28507082.
Rai P, Niss O, Malik P (November 2017). "A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia". Pediatric Blood & Cancer. 64 (11): e26607. doi:10.1002/pbc.26607. PMID 28453224. S2CID 24444332.
Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, et al. (October 1991). "Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality". Annals of Internal Medicine. 115 (8): 614–620. doi:10.7326/0003-4819-115-8-614. PMID 1892333.
Sankaran VG, Orkin SH (January 2013). "The switch from fetal to adult hemoglobin". Cold Spring Harbor Perspectives in Medicine. 3 (1): a011643. doi:10.1101/cshperspect.a011643. PMC 3530042. PMID 23209159.
Green NS, Fabry ME, Kaptue-Noche L, Nagel RL (October 1993). "Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia". American Journal of Hematology. 44 (2): 145–146. doi:10.1002/ajh.2830440214. PMID 7505527. S2CID 27341091.
Odièvre MH, Verger E, Silva-Pinto AC, Elion J (October 2011). "Pathophysiological insights in sickle cell disease". The Indian Journal of Medical Research. 134 (1): 532–537. doi:10.1007/bf00168807. PMC 3237253. PMID 22089617.
Allison AC (October 2009). "Genetic control of resistance to human malaria". Current Opinion in Immunology. 21 (5): 499–505. doi:10.1016/j.coi.2009.04.001. PMID 19442502.
Kwiatkowski DP (August 2005). "How malaria has affected the human genome and what human genetics can teach us about malaria". American Journal of Human Genetics. 77 (2): 171–192. doi:10.1086/432519. PMC 1224522. PMID 16001361.
Ponçon N, Toty C, L'Ambert G, Le Goff G, Brengues C, Schaffner F, et al. (February 2007). "Biology and dynamics of potential malaria vectors in Southern France". Malaria Journal. 6 (1): 18. doi:10.1186/1475-2875-6-18. PMC 1808464. PMID 17313664.
Lesi FE, Bassey EE (July 1972). "Family study in sickle cell disease in Nigeria". Journal of Biosocial Science. 4 (3): 307–313. doi:10.1017/S0021932000008622. PMID 5041262. S2CID 41719342.
Kruzliak P (19 July 2012), "Hematologic manifestations of celiac disease", Celiac Disease – From Pathophysiology to Advanced Therapies, InTech, doi:10.5772/31233, ISBN 978-953-51-0684-5
Clarke GM, Higgins TN (August 2000). "Laboratory investigation of hemoglobinopathies and thalassemias: review and update". Clinical Chemistry. 46 (8 Pt 2): 1284–1290. doi:10.1093/clinchem/46.8.1284. PMID 10926923. Archived from the original on 20 March 2008.
Goldsmith JC, Bonham VL, Joiner CH, Kato GJ, Noonan AS, Steinberg MH (March 2012). "Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications". American Journal of Hematology. 87 (3): 340–346. doi:10.1002/ajh.22271. PMC 3513289. PMID 22307997.
Bonham VL, Dover GJ, Brody LC (September 2010). "Screening student athletes for sickle cell trait--a social and clinical experiment". The New England Journal of Medicine. 363 (11): 997–999. doi:10.1056/NEJMp1007639. PMID 20825310.
Acharya K, Benjamin HJ, Clayton EW, Ross LF (November 2011). "Attitudes and beliefs of sports medicine providers to sickle cell trait screening of student athletes". Clinical Journal of Sport Medicine. 21 (6): 480–485. doi:10.1097/JSM.0b013e31822e8634. PMID 21959797. S2CID 11404187.
Ferrari R, Parker LS, Grubs RE, Krishnamurti L (December 2015). "Sickle Cell Trait Screening of Collegiate Athletes: Ethical Reasons for Program Reform". Journal of Genetic Counseling. 24 (6): 873–877. doi:10.1007/s10897-015-9849-1. PMID 26040250. S2CID 15889144.
Martin C, Pialoux V, Faes C, Charrin E, Skinner S, Connes P (February 2018). "Does physical activity increase or decrease the risk of sickle cell disease complications?". British Journal of Sports Medicine. 52 (4): 214–218. doi:10.1136/bjsports-2015-095317. PMID 26701924. S2CID 24464344.
Soe HH, Abas AB, Than NN, Ni H, Singh J, Said AR, et al. (May 2020). "Vitamin D supplementation for sickle cell disease". The Cochrane Database of Systematic Reviews. 5 (9): CD010858. doi:10.1002/14651858.CD010858.pub3. PMC 7386793. PMID 32462740.
Dixit R, Nettem S, Madan SS, Soe HH, Abas AB, Vance LD, et al. (March 2018). "Folate supplementation in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 3 (4): CD011130. doi:10.1002/14651858.CD011130.pub3. PMC 5440187. PMID 29546732.
Oniyangi O, Omari AA (November 2019). "Malaria chemoprophylaxis in sickle cell disease". The Cochrane Database of Systematic Reviews. 2019 (11). doi:10.1002/14651858.CD003489.pub2. PMC 6532723. PMID 31681984.
Carroll CP (January 2020). "Opioid treatment for acute and chronic pain in patients with sickle cell disease". Neuroscience Letters. 714. Elsevier BV: 134534. doi:10.1016/j.neulet.2019.134534. PMID 31593753. S2CID 203667575.
Okomo U, Meremikwu MM (July 2017). "Fluid replacement therapy for acute episodes of pain in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 7 (4): CD005406. doi:10.1002/14651858.CD005406.pub5. PMC 6483538. PMID 28759112.
Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. (July 1998). "Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography". The New England Journal of Medicine. 339 (1): 5–11. doi:10.1056/NEJM199807023390102. PMID 9647873.
Martí-Carvajal AJ, Conterno LO, Knight-Madden JM (September 2019). "Antibiotics for treating acute chest syndrome in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 9 (4): CD006110. doi:10.1002/14651858.CD006110.pub5. PMC 6749554. PMID 31531967.
Dolatkhah R, Dastgiri S (January 2020). "Blood transfusions for treating acute chest syndrome in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 1 (1): CD007843. doi:10.1002/14651858.CD007843.pub4. PMC 6984655. PMID 31942751.
Rankine-Mullings AE, Nevitt SJ (September 2022). "Hydroxyurea (hydroxycarbamide) for sickle cell disease". The Cochrane Database of Systematic Reviews. 2022 (10): CD002202. doi:10.1002/14651858.CD002202.pub3. PMC 9435593. PMID 36047926.
Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. (May 1995). "Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia". The New England Journal of Medicine. 332 (20): 1317–1322. doi:10.1056/NEJM199505183322001. PMID 7715639.
Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. (April 2003). "Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment". The Journal of the American Medical Association. 289 (13): 1645–1651. doi:10.1001/jama.289.13.1645. PMID 12672732.
Platt OS (March 2008). "Hydroxyurea for the treatment of sickle cell anemia". The New England Journal of Medicine. 358 (13): 1362–1369. doi:10.1056/NEJMct0708272. PMID 18367739. S2CID 351061.
Drasar E, Igbineweka N, Vasavda N, Free M, Awogbade M, Allman M, et al. (March 2011). "Blood transfusion usage among adults with sickle cell disease – a single institution experience over ten years". British Journal of Haematology. 152 (6): 766–770. doi:10.1111/j.1365-2141.2010.08451.x. PMID 21275951. S2CID 44562296.
Gyang E, Yeom K, Hoppe C, Partap S, Jeng M (January 2011). "Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease". American Journal of Hematology. 86 (1): 104–106. doi:10.1002/ajh.21901. PMID 21117059.
Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, et al. (March 2010). "Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease". European Journal of Haematology. 84 (3): 259–265. doi:10.1111/j.1600-0609.2009.01379.x. PMID 19912310. S2CID 24316310.
Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, et al. (August 1996). "Bone marrow transplantation for sickle cell disease". The New England Journal of Medicine. 335 (6): 369–376. doi:10.1056/NEJM199608083350601. PMID 8663884. S2CID 25256772.
Callaway D, Chawla A, Sprinz P (November 2020). "Physical Therapy in Pediatric and Young Adult Patients With Sickle Cell Disease: Assessing Potential Benefits and Barriers". Journal of Pediatric Hematology/Oncology. 42 (8): 463–466. doi:10.1097/MPH.0000000000001888. ISSN 1536-3678. PMID 32815878.
Zanoni CT, Galvão F, Maria RM, Zulli R, Ricciardi JB, Cliquet a J, et al. (2020). "Effectiveness of a home-based therapeutic exercise program on lower back pain and functionality in Sickle Cell Disease (SCD) patients". Hematology, Transfusion and Cell Therapy. 43 (3): 268–279. doi:10.1016/j.htct.2020.05.004. PMC 8446254. PMID 32680757.
Wierenga KJ, Hambleton IR, Lewis NA (March 2001). "Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study". Lancet. 357 (9257): 680–683. doi:10.1016/s0140-6736(00)04132-5. PMID 11247552. S2CID 37012133.
Prabhakar H, Haywood C, Molokie R (May 2010). "Sickle cell disease in the United States: looking back and forward at 100 years of progress in management and survival". American Journal of Hematology. 85 (5): 346–353. doi:10.1002/ajh.21676. PMID 20425797.
Roberts I, de Montalembert M (July 2007). "Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe". Haematologica. 92 (7): 865–871. doi:10.3324/haematol.11474. PMID 17606434.
Wellems TE, Hayton K, Fairhurst RM (September 2009). "The impact of malaria parasitism: from corpuscles to communities". The Journal of Clinical Investigation. 119 (9): 2496–2505. doi:10.1172/JCI38307. PMC 2735907. PMID 19729847.
Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, et al. (April 2002). "Protective effects of the sickle cell gene against malaria morbidity and mortality". Lancet. 359 (9314): 1311–1312. doi:10.1016/S0140-6736(02)08273-9. PMID 11965279. S2CID 37952036.
Tusuubira SK, Nakayinga R, Mwambi B, Odda J, Kiconco S, Komuhangi A (April 2018). "Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda". BMC Public Health. 18 (1): 561. doi:10.1186/s12889-018-5496-4. PMC 5924488. PMID 29703184.
Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, et al. (March 2016). "Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study". The Lancet. Global Health. 4 (3): e195–e200. doi:10.1016/S2214-109X(15)00288-0. PMID 26833239.
Edwards QT, Seibert D, Macri C, Covington C, Tilghman J (November 2004). "Assessing ethnicity in preconception counseling: genetics—what nurse practitioners need to know". Journal of the American Academy of Nurse Practitioners. 16 (11): 472–480. doi:10.1111/j.1745-7599.2004.tb00426.x. PMID 15617360. S2CID 7644129.
Vlachadis N, Vrachnis N (15 November 2022). "A Review of Sickle Cell Disease". JAMA. 328 (19): 1979. doi:10.1001/jama.2022.16732. ISSN 0098-7484. PMID 36378213.
Beillat M, Durand-Zaleski I, Pirenne F, Bénard S, Chillotti L, Galacteros F (21 September 2023). "Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires". Frontiers in Public Health. 11: 1215605. doi:10.3389/fpubh.2023.1215605. PMC 10552641. PMID 37808997.
Thuret I, Sarles J, Merono F, Suzineau E, Collomb J, Lena-Russo D, et al. (June 2010). "Neonatal screening for sickle cell disease in France: evaluation of the selective process". Journal of Clinical Pathology. 63 (6): 548–551. doi:10.1136/jcp.2009.068874. PMID 20498028. S2CID 22391674.
Jastaniah W (2011). "Epidemiology of sickle cell disease in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 289–293. doi:10.4103/0256-4947.81540. PMC 3119971. PMID 21623060.
Memish ZA, Saeedi MY (2011). "Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 229–235. doi:10.4103/0256-4947.81527. PMC 3119961. PMID 21623050.
Al Arrayed S, Al Hajeri A (2010). "Public awareness of sickle cell disease in Bahrain". Annals of Saudi Medicine. 30 (4): 284–288. doi:10.4103/0256-4947.65256. PMC 2931779. PMID 20622345.
Awasthy N, Aggarwal KC, Goyal PC, Prasad MS, Saluja S, Sharma M (2008). "Sickle cell disease: Experience of a tertiary care center in a nonendemic area". Annals of Tropical Medicine and Public Health. 1 (1): 1–4. doi:10.4103/1755-6783.43069 (inactive 22 June 2024).{{cite journal}}: CS1 maint: DOI inactive as of June 2024 (link)
Asnani MR, McCaw-Binns AM, Reid ME (2011). "Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007". PLOS ONE. 6 (10): e26281. Bibcode:2011PLoSO...626281A. doi:10.1371/journal.pone.0026281. PMC 3200316. PMID 22039456.
Ballas SK, Gupta K, Adams-Graves P (November 2012). "Sickle cell pain: a critical reappraisal". Blood. 120 (18): 3647–3656. doi:10.1182/blood-2012-04-383430. PMID 22923496.
Herrick JB (1 November 1910). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia". Archives of Internal Medicine. 6 (5): 179–184. doi:10.1001/archinte.1910.00050330050003.; reprinted as Herrick JB (2001). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910". The Yale Journal of Biology and Medicine. 74 (3): 179–184. PMC 2588723. PMID 11501714.
Mason VR (1922). "Sickle cell anemia". The Journal of the American Medical Association. 79 (16): 1318–1320. doi:10.1001/jama.1922.02640160038012. Reprinted in Mason VR (October 1985). "Landmark article Oct. 14, 1922: Sickle cell anemia. By V.R. Mason". The Journal of the American Medical Association. 254 (14): 1955–1957. doi:10.1001/jama.254.14.1955. PMID 3900438.
Pauling L, Itano HA (November 1949). "Sickle cell anemia a molecular disease". Science. 110 (2865): 543–548. Bibcode:1949Sci...110..543P. doi:10.1126/science.110.2865.543. PMID 15395398. S2CID 31674765.
Ingram VM (October 1956). "A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin". Nature. 178 (4537): 792–794. Bibcode:1956Natur.178..792I. doi:10.1038/178792a0. PMID 13369537. S2CID 4167855.
Srikanthan S (2023). "Contested Disability: Sickle Cell Disease". Health & Social Work. 48 (3): 209–216. doi:10.1093/hsw/hlad014. PMID 37315205.
Bulgin D, Tanabe P, Jenerette C (August 2018). "Stigma of Sickle Cell Disease: A Systematic Review". Issues in Mental Health Nursing. 39 (8): 675–686. doi:10.1080/01612840.2018.1443530. PMC 6186193. PMID 29652215.
Tusuubira SK, Naggawa T, Nakamoga V (October 2019). "To Join Or Not To Join? A Case Of Sickle Cell Clubs, Stigma And Discrimination In Secondary Schools In Butambala District, Uganda". Adolescent Health, Medicine and Therapeutics. 10: 145–152. doi:10.2147/AHMT.S223956. PMC 6778728. PMID 31632168.
Tusuubira SK, Nakayinga R, Mwambi B, Odda J, Kiconco S, Komuhangi A (April 2018). "Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda". BMC Public Health. 18 (1): 561. doi:10.1186/s12889-018-5496-4. PMC 5924488. PMID 29703184.
Okwi AL, Byarugaba W, Ndugwa CM, Parkes A, Ocaido M, Tumwine JK (September 2009). "Knowledge gaps, attitude and beliefs of the communities about sickle cell disease in Eastern and Western Uganda". East African Medical Journal. 86 (9): 442–449. doi:10.4314/eamj.v86i9.54167. PMID 21644415.
Marsh VM, Kamuya DM, Molyneux SS (August 2011). "'All her children are born that way': gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya". Ethnicity & Health. 16 (4–5): 343–359. doi:10.1080/13557858.2010.541903. PMC 3534410. PMID 21797722.
Sehlo MG, Kamfar HZ (April 2015). "Depression and quality of life in children with sickle cell disease: the effect of social support". BMC Psychiatry. 15 (1): 78. doi:10.1186/s12888-015-0461-6. PMC 4394397. PMID 25880537.
Kassim AA, Sharma D (December 2017). "Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape". Hematology/Oncology and Stem Cell Therapy. 10 (4): 259–266. doi:10.1016/j.hemonc.2017.05.008. PMID 28641096.
Olowoyeye A, Okwundu CI (November 2020). "Gene therapy for sickle cell disease". The Cochrane Database of Systematic Reviews. 2020 (11): CD007652. doi:10.1002/14651858.CD007652.pub7. PMC 8275984. PMID 33251574.
Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, et al. (December 2001). "Correction of sickle cell disease in transgenic mouse models by gene therapy". Science. 294 (5550): 2368–2371. Bibcode:2001Sci...294.2368P. doi:10.1126/science.1065806. PMID 11743206. S2CID 25607771.
Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. (March 2017). "Gene Therapy in a Patient with Sickle Cell Disease". The New England Journal of Medicine. 376 (9): 848–855. doi:10.1056/NEJMoa1609677. PMID 28249145. S2CID 5128871.
Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, et al. (November 2016). "CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells". Nature. 539 (7629): 384–389. Bibcode:2016Natur.539..384D. doi:10.1038/nature20134. PMC 5898607. PMID 27820943.
Zipkin M (6 December 2019). "CRISPR's "magnificent moment" in the clinic". Nature Biotechnology. doi:10.1038/d41587-019-00035-2. PMID 33277639. S2CID 213060203.
Persaud A, Desine S, Blizinsky K, Bonham VL (August 2019). "A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease community". Genetics in Medicine. 21 (8): 1726–1734. doi:10.1038/s41436-018-0409-6. PMC 6606394. PMID 30581191.
Oringanje C, Nemecek E, Oniyangi O (July 2020). "Hematopoietic stem cell transplantation for people with sickle cell disease". The Cochrane Database of Systematic Reviews. 2020 (7): CD007001. doi:10.1002/14651858.CD007001.pub5. PMC 7390490. PMID 32617981.

dx.doi.org

Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. (15 July 1995). "Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease [see comments]". Blood. 86 (2): 776–783. doi:10.1182/blood.v86.2.776.bloodjournal862776. ISSN 0006-4971.

eatright.org

"Nutrition for the Child with Sickle Cell Anemia". www.eatright.org. Archived from the original on 19 June 2020. Retrieved 5 October 2019.

england.nhs.uk

"NHS launches lifesaving sickle cell campaign". 7 October 2022.

eurekaselect.com

Fibach E, Rachmilewitz E (2008). "The Role of Oxidative Stress in Hemolytic Anemia". Current Molecular Medicine. 8 (7): 609–619. doi:10.2174/156652408786241384. PMID 18991647.

europa.eu

ema.europa.eu

"EMA recommends suspension of sickle cell disease medicine Oxbryta | European Medicines Agency (EMA)". www.ema.europa.eu. 26 September 2024. Retrieved 11 October 2024.

fda.gov

"FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease". U.S. Food and Drug Administration (FDA). 8 December 2023. Archived from the original on 8 December 2023. Retrieved 8 December 2023. This article incorporates text from this source, which is in the public domain.
Office of the Commissioner (7 July 2017). "Press Announcements – FDA approves new treatment for sickle cell disease". www.fda.gov. Archived from the original on 10 July 2017. Retrieved 10 July 2017.
"FDA approves crizanlizumab-tmca for sickle cell disease". U.S. Food and Drug Administration. 15 November 2019. Retrieved 12 December 2023.
Center for Drug Evaluation and Research (25 November 2019). "FDA approves voxelotor for sickle cell disease". FDA. Retrieved 9 December 2019.
Research Cf (26 September 2024). "FDA is alerting patients and health care professionals about the voluntary withdrawal of Oxbryta from the market due to safety concerns". FDA.

fofweb.com

"Foster, Gloria". Facts On File History Database. Archived from the original on 5 March 2016. Retrieved 25 February 2015.

genome.gov

"Learning About Sickle Cell Disease". National Human Genome Research Institute. 9 May 2016. Archived from the original on 4 January 2017. Retrieved 23 January 2017.

gov.uk

"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". Medicines and Healthcare products Regulatory Agency (MHRA) (Press release). 16 November 2023. Archived from the original on 25 November 2023. Retrieved 8 December 2023.

gpo.gov

"Federal Register, Volume 82 Issue 178 (Friday, September 15, 2017)". U.S. Government Publishing Office (GPO). Retrieved 15 January 2018.

harvard.edu

ui.adsabs.harvard.edu

Asnani MR, McCaw-Binns AM, Reid ME (2011). "Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007". PLOS ONE. 6 (10): e26281. Bibcode:2011PLoSO...626281A. doi:10.1371/journal.pone.0026281. PMC 3200316. PMID 22039456.
Pauling L, Itano HA (November 1949). "Sickle cell anemia a molecular disease". Science. 110 (2865): 543–548. Bibcode:1949Sci...110..543P. doi:10.1126/science.110.2865.543. PMID 15395398. S2CID 31674765.
Ingram VM (October 1956). "A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin". Nature. 178 (4537): 792–794. Bibcode:1956Natur.178..792I. doi:10.1038/178792a0. PMID 13369537. S2CID 4167855.
Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, et al. (December 2001). "Correction of sickle cell disease in transgenic mouse models by gene therapy". Science. 294 (5550): 2368–2371. Bibcode:2001Sci...294.2368P. doi:10.1126/science.1065806. PMID 11743206. S2CID 25607771.
Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, et al. (November 2016). "CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells". Nature. 539 (7629): 384–389. Bibcode:2016Natur.539..384D. doi:10.1038/nature20134. PMC 5898607. PMID 27820943.

sickle.bwh.harvard.edu

"How Does Sickle Cell Cause Disease?". Archived from the original on 23 September 2010. Retrieved 27 November 2010.

healthaimed.com

Dudi A (17 November 2023). "Unravelito the Quest: Is There a Cure for Sickle Cell Anemia? Introduction to Sickle Cell Anemia". Health aimed. Retrieved 17 November 2023.

healthlinkbc.ca

"Blood Transfusions for Sickle Cell Disease | HealthLink BC". www.healthlinkbc.ca. Retrieved 8 May 2024.

hematology.org

"Statement on Screening for Sickle Cell Trait and Athletic Participation". American Society of Hematology. Archived from the original on 26 January 2021. Retrieved 24 February 2021.
"Sickle Cell Trait". American Society of Hematology. 8 September 2017. Retrieved 13 December 2019.
"Sickle Cell Anemia". American Society of Hematology. 16 December 2014. Archived from the original on 25 June 2017. Retrieved 1 May 2017.

hsj.co.uk

"London Eye: Shouldn't need an improvement programme". Health Service Journal. 27 July 2022. Retrieved 28 September 2022.

jamanetwork.com

Vlachadis N, Vrachnis N (15 November 2022). "A Review of Sickle Cell Disease". JAMA. 328 (19): 1979. doi:10.1001/jama.2022.16732. ISSN 0098-7484. PMID 36378213.

jbjs.org

Worrall VT, Butera V (December 1976). "Sickle-cell dactylitis". The Journal of Bone and Joint Surgery. American Volume. 58 (8): 1161–1163. doi:10.2106/00004623-197658080-00024. PMID 1002763. Archived from the original on 23 September 2016.

jefferson.edu

jdc.jefferson.edu

Ballas SK, Gupta K, Adams-Graves P (November 2012). "Sickle cell pain: a critical reappraisal". Blood. 120 (18): 3647–3656. doi:10.1182/blood-2012-04-383430. PMID 22923496.

lecturio.com

"Cholelithiasis". The Lecturio Medical Concept Library. Retrieved 25 August 2021.

medlineplus.gov

"Sickle cell disease: MedlinePlus Genetics". medlineplus.gov. Retrieved 22 October 2022.
United States National Library of Medicine. "Sickle cell disease: MedlinePlus Genetics".

medscape.com

emedicine.medscape.com

"Sickle Cell Anemia: eMedicine Emergency Medicine". Archived from the original on 4 December 2010. Retrieved 27 November 2010.

nationalmssociety.org

"Empowering people affected by MS to live their best lives". National Multiple Sclerosis Society. Retrieved 8 May 2024.

nature.com

"Sickle-Cell Anemia: Haplotype | Learn Science at Scitable". www.nature.com. Retrieved 12 October 2023.
Clancy S (2008). "Genetic mutation". Nature Education. 1 (1): 187.
Zipkin M (6 December 2019). "CRISPR's "magnificent moment" in the clinic". Nature Biotechnology. doi:10.1038/d41587-019-00035-2. PMID 33277639. S2CID 213060203.

nepalitimes.com

"Life with sickle cell – Nation – Nepali Times". Archived from the original on 24 June 2015.

newbornscreening.info

"Disorder Name: Sickle Cell Disease". New Born Screening. Archived from the original on 28 September 2016. Retrieved 11 October 2016.

nhs.uk

"Inheriting sickle cell anaemia – Live Well – NHS Choices". www.nhs.uk. 23 October 2017. Archived from the original on 2 December 2014.
"Sickle cell anaemia – NHS Choices". www.nhs.uk. 23 October 2017. Archived from the original on 13 December 2011.

nih.gov

pubmed.ncbi.nlm.nih.gov

Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Nelson MD, Bennett DM, Lehman ME, Okonji AI (5 December 2022). "Dizziness, Falls, and Hearing Loss in Adults Living With Sickle Cell Disease". American Journal of Audiology. 31 (4): 1178–1190. doi:10.1044/2022_AJA-22-00059. ISSN 1558-9137. PMID 36251873.
Wilkinson E (16 November 2023). "UK regulator approves "groundbreaking" gene treatment for sickle cell and β thalassaemia". BMJ. 383: 2706. doi:10.1136/bmj.p2706. ISSN 1756-1833. PMID 37973171. S2CID 265264939.
Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (Global Burden of Disease Study 2013 Collaborators) (August 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 386 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472.
Rees DC, Williams TN, Gladwin MT (December 2010). "Sickle-cell disease". Lancet. 376 (9757): 2018–2031. doi:10.1016/s0140-6736(10)61029-x. PMID 21131035. S2CID 29909566.
Savitt TL, Goldberg MF (January 1989). "Herrick's 1910 case report of sickle cell anemia. The rest of the story". The Journal of the American Medical Association. 261 (2): 266–271. doi:10.1001/jama.261.2.266. PMID 2642320.
Serjeant GR (December 2010). "One hundred years of sickle cell disease". British Journal of Haematology. 151 (5): 425–429. doi:10.1111/j.1365-2141.2010.08419.x. PMID 20955412.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. (September 2014). "Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members". The Journal of the American Medical Association. 312 (10): 1033–1048. doi:10.1001/jama.2014.10517. PMID 25203083. S2CID 37681044.
Olujohungbe A, Burnett AL (March 2013). "How I manage priapism due to sickle cell disease". British Journal of Haematology. 160 (6): 754–765. doi:10.1111/bjh.12199. PMID 23293942.
Glassberg J (August 2011). "Evidence-based management of sickle cell disease in the emergency department". Emergency Medicine Practice. 13 (8): 1–20, quiz 20. PMID 22164362.
Anie KA, Green J (May 2015). "Psychological therapies for sickle cell disease and pain". The Cochrane Database of Systematic Reviews. 2015 (5): CD001916. doi:10.1002/14651858.CD001916.pub3. PMC 7063720. PMID 25966336.
Pearson HA (August 1977). "Sickle cell anemia and severe infections due to encapsulated bacteria" (Free full text). The Journal of Infectious Diseases. 136 (Suppl): S25–S30. doi:10.1093/infdis/136.Supplement.S25. PMID 330779. Archived from the original on 27 May 2016.
Wong WY, Powars DR, Chan L, Hiti A, Johnson C, Overturf G (March 1992). "Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience". American Journal of Hematology. 39 (3): 176–182. doi:10.1002/ajh.2830390305. PMID 1546714. S2CID 19977178.
Khatib R, Rabah R, Sarnaik SA (January 2009). "The spleen in the sickling disorders: an update". Pediatric Radiology. 39 (1): 17–22. doi:10.1007/s00247-008-1049-9. PMID 19002450. S2CID 2547649.
Mekontso Dessap A, Leon R, Habibi A, Nzouakou R, Roudot-Thoraval F, Adnot S, et al. (March 2008). "Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease". American Journal of Respiratory and Critical Care Medicine. 177 (6): 646–653. CiteSeerX 10.1.1.504.790. doi:10.1164/rccm.200710-1606OC. PMID 18174543.
Paul RN, Castro OL, Aggarwal A, Oneal PA (September 2011). "Acute chest syndrome: sickle cell disease". European Journal of Haematology. 87 (3): 191–207. doi:10.1111/j.1600-0609.2011.01647.x. PMID 21615795. S2CID 40320701.
Slavov SN, Kashima S, Pinto AC, Covas DT (August 2011). "Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions". FEMS Immunology and Medical Microbiology. 62 (3): 247–262. doi:10.1111/j.1574-695X.2011.00819.x. PMID 21585562.
Balgir RS (March 2012). "Community expansion and gene geography of sickle cell trait and G6PD deficiency, and natural selection against malaria: experience from tribal land of India". Cardiovascular & Hematological Agents in Medicinal Chemistry. 10 (1): 3–13. doi:10.2174/187152512799201190. PMID 22264009.
Fibach E, Rachmilewitz E (2008). "The Role of Oxidative Stress in Hemolytic Anemia". Current Molecular Medicine. 8 (7): 609–619. doi:10.2174/156652408786241384. PMID 18991647.
Jadavji T, Prober CG (April 1985). "Dactylitis in a child with sickle cell trait". Canadian Medical Association Journal. 132 (7): 814–815. PMC 1345873. PMID 3978504.
Worrall VT, Butera V (December 1976). "Sickle-cell dactylitis". The Journal of Bone and Joint Surgery. American Volume. 58 (8): 1161–1163. doi:10.2106/00004623-197658080-00024. PMID 1002763. Archived from the original on 23 September 2016.
Miller ST (May 2011). "How I treat acute chest syndrome in children with sickle cell disease". Blood. 117 (20): 5297–5305. doi:10.1182/blood-2010-11-261834. PMID 21406723. S2CID 206896811.
Friend A, Girzadas D (2021). "Acute Chest Syndrome". StatPearls. StatPearls Publishing. PMID 28722902. Retrieved 21 March 2021.
Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ (December 2011). "Management of children with sickle cell disease: a comprehensive review of the literature". Pediatrics. 128 (6): e1552–e1574. doi:10.1542/peds.2010-3686. PMID 22123880. S2CID 14524078. Archived from the original on 4 March 2016.
Adams RJ, Ohene-Frempong K, Wang W (2001). "Sickle cell and the brain". Hematology. American Society of Hematology. Education Program. 2001 (1): 31–46. doi:10.1182/asheducation-2001.1.31. PMID 11722977.
Adams RJ (November 2007). "Big strokes in small persons". Archives of Neurology. 64 (11): 1567–1574. doi:10.1001/archneur.64.11.1567. PMID 17998439.
Martí-Carvajal AJ, Solà I, Agreda-Pérez LH (December 2019). "Treatment for avascular necrosis of bone in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 2019 (12): CD004344. doi:10.1002/14651858.CD004344.pub7. PMC 6894369. PMID 31803937.
Kenny MW, George AJ, Stuart J (July 1980). "Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism". Journal of Clinical Pathology. 33 (7): 622–625. doi:10.1136/jcp.33.7.622. PMC 1146172. PMID 7430367.
Chrouser KL, Ajiboye OB, Oyetunji TA, Chang DC (April 2011). "Priapism in the United States: the changing role of sickle cell disease". American Journal of Surgery. 201 (4): 468–474. doi:10.1016/j.amjsurg.2010.03.017. PMID 21421100.
Almeida A, Roberts I (May 2005). "Bone involvement in sickle cell disease". British Journal of Haematology. 129 (4): 482–490. doi:10.1111/j.1365-2141.2005.05476.x. PMID 15877730. S2CID 908481.
Elagouz M, Jyothi S, Gupta B, Sivaprasad S (July 2010). "Sickle cell disease and the eye: old and new concepts". Survey of Ophthalmology. 55 (4): 359–377. doi:10.1016/j.survophthal.2009.11.004. PMID 20452638.
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. (January 2008). "Daily assessment of pain in adults with sickle cell disease". Annals of Internal Medicine. 148 (2): 94–101. CiteSeerX 10.1.1.690.5870. doi:10.7326/0003-4819-148-2-200801150-00004. PMID 18195334. S2CID 34924760.
Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT (June 2014). "Pulmonary arterial hypertension: the clinical syndrome". Circulation Research. 115 (1): 115–130. doi:10.1161/CIRCRESAHA.115.301146. PMC 4096686. PMID 24951762.
Caughey MC, Poole C, Ataga KI, Hinderliter AL (August 2015). "Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review". British Journal of Haematology. 170 (3): 416–424. doi:10.1111/bjh.13447. PMID 25854714. S2CID 23920740.
Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, et al. (March 2016). "Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease". JACC. Cardiovascular Imaging. 9 (3): 243–252. doi:10.1016/j.jcmg.2015.05.013. PMC 4788530. PMID 26897687.
Niss O, Fleck R, Makue F, Alsaied T, Desai P, Towbin JA, et al. (July 2017). "Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia". Blood. 130 (2): 205–213. doi:10.1182/blood-2017-02-767624. PMC 5510791. PMID 28507082.
Rai P, Niss O, Malik P (November 2017). "A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia". Pediatric Blood & Cancer. 64 (11): e26607. doi:10.1002/pbc.26607. PMID 28453224. S2CID 24444332.
Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, et al. (October 1991). "Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality". Annals of Internal Medicine. 115 (8): 614–620. doi:10.7326/0003-4819-115-8-614. PMID 1892333.
Sankaran VG, Orkin SH (January 2013). "The switch from fetal to adult hemoglobin". Cold Spring Harbor Perspectives in Medicine. 3 (1): a011643. doi:10.1101/cshperspect.a011643. PMC 3530042. PMID 23209159.
Green NS, Fabry ME, Kaptue-Noche L, Nagel RL (October 1993). "Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia". American Journal of Hematology. 44 (2): 145–146. doi:10.1002/ajh.2830440214. PMID 7505527. S2CID 27341091.
Odièvre MH, Verger E, Silva-Pinto AC, Elion J (October 2011). "Pathophysiological insights in sickle cell disease". The Indian Journal of Medical Research. 134 (1): 532–537. doi:10.1007/bf00168807. PMC 3237253. PMID 22089617.
Allison AC (October 2009). "Genetic control of resistance to human malaria". Current Opinion in Immunology. 21 (5): 499–505. doi:10.1016/j.coi.2009.04.001. PMID 19442502.
Kwiatkowski DP (August 2005). "How malaria has affected the human genome and what human genetics can teach us about malaria". American Journal of Human Genetics. 77 (2): 171–192. doi:10.1086/432519. PMC 1224522. PMID 16001361.
Ponçon N, Toty C, L'Ambert G, Le Goff G, Brengues C, Schaffner F, et al. (February 2007). "Biology and dynamics of potential malaria vectors in Southern France". Malaria Journal. 6 (1): 18. doi:10.1186/1475-2875-6-18. PMC 1808464. PMID 17313664.
Lesi FE, Bassey EE (July 1972). "Family study in sickle cell disease in Nigeria". Journal of Biosocial Science. 4 (3): 307–313. doi:10.1017/S0021932000008622. PMID 5041262. S2CID 41719342.
Clarke GM, Higgins TN (August 2000). "Laboratory investigation of hemoglobinopathies and thalassemias: review and update". Clinical Chemistry. 46 (8 Pt 2): 1284–1290. doi:10.1093/clinchem/46.8.1284. PMID 10926923. Archived from the original on 20 March 2008.
Goldsmith JC, Bonham VL, Joiner CH, Kato GJ, Noonan AS, Steinberg MH (March 2012). "Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications". American Journal of Hematology. 87 (3): 340–346. doi:10.1002/ajh.22271. PMC 3513289. PMID 22307997.
Bonham VL, Dover GJ, Brody LC (September 2010). "Screening student athletes for sickle cell trait--a social and clinical experiment". The New England Journal of Medicine. 363 (11): 997–999. doi:10.1056/NEJMp1007639. PMID 20825310.
Acharya K, Benjamin HJ, Clayton EW, Ross LF (November 2011). "Attitudes and beliefs of sports medicine providers to sickle cell trait screening of student athletes". Clinical Journal of Sport Medicine. 21 (6): 480–485. doi:10.1097/JSM.0b013e31822e8634. PMID 21959797. S2CID 11404187.
Ferrari R, Parker LS, Grubs RE, Krishnamurti L (December 2015). "Sickle Cell Trait Screening of Collegiate Athletes: Ethical Reasons for Program Reform". Journal of Genetic Counseling. 24 (6): 873–877. doi:10.1007/s10897-015-9849-1. PMID 26040250. S2CID 15889144.
Martin C, Pialoux V, Faes C, Charrin E, Skinner S, Connes P (February 2018). "Does physical activity increase or decrease the risk of sickle cell disease complications?". British Journal of Sports Medicine. 52 (4): 214–218. doi:10.1136/bjsports-2015-095317. PMID 26701924. S2CID 24464344.
Soe HH, Abas AB, Than NN, Ni H, Singh J, Said AR, et al. (May 2020). "Vitamin D supplementation for sickle cell disease". The Cochrane Database of Systematic Reviews. 5 (9): CD010858. doi:10.1002/14651858.CD010858.pub3. PMC 7386793. PMID 32462740.
Dixit R, Nettem S, Madan SS, Soe HH, Abas AB, Vance LD, et al. (March 2018). "Folate supplementation in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 3 (4): CD011130. doi:10.1002/14651858.CD011130.pub3. PMC 5440187. PMID 29546732.
Oniyangi O, Omari AA (November 2019). "Malaria chemoprophylaxis in sickle cell disease". The Cochrane Database of Systematic Reviews. 2019 (11). doi:10.1002/14651858.CD003489.pub2. PMC 6532723. PMID 31681984.
Carroll CP (January 2020). "Opioid treatment for acute and chronic pain in patients with sickle cell disease". Neuroscience Letters. 714. Elsevier BV: 134534. doi:10.1016/j.neulet.2019.134534. PMID 31593753. S2CID 203667575.
Okomo U, Meremikwu MM (July 2017). "Fluid replacement therapy for acute episodes of pain in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 7 (4): CD005406. doi:10.1002/14651858.CD005406.pub5. PMC 6483538. PMID 28759112.
Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. (July 1998). "Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography". The New England Journal of Medicine. 339 (1): 5–11. doi:10.1056/NEJM199807023390102. PMID 9647873.
Martí-Carvajal AJ, Conterno LO, Knight-Madden JM (September 2019). "Antibiotics for treating acute chest syndrome in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 9 (4): CD006110. doi:10.1002/14651858.CD006110.pub5. PMC 6749554. PMID 31531967.
Dolatkhah R, Dastgiri S (January 2020). "Blood transfusions for treating acute chest syndrome in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 1 (1): CD007843. doi:10.1002/14651858.CD007843.pub4. PMC 6984655. PMID 31942751.
Rankine-Mullings AE, Nevitt SJ (September 2022). "Hydroxyurea (hydroxycarbamide) for sickle cell disease". The Cochrane Database of Systematic Reviews. 2022 (10): CD002202. doi:10.1002/14651858.CD002202.pub3. PMC 9435593. PMID 36047926.
Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. (May 1995). "Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia". The New England Journal of Medicine. 332 (20): 1317–1322. doi:10.1056/NEJM199505183322001. PMID 7715639.
Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. (April 2003). "Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment". The Journal of the American Medical Association. 289 (13): 1645–1651. doi:10.1001/jama.289.13.1645. PMID 12672732.
Platt OS (March 2008). "Hydroxyurea for the treatment of sickle cell anemia". The New England Journal of Medicine. 358 (13): 1362–1369. doi:10.1056/NEJMct0708272. PMID 18367739. S2CID 351061.
Drasar E, Igbineweka N, Vasavda N, Free M, Awogbade M, Allman M, et al. (March 2011). "Blood transfusion usage among adults with sickle cell disease – a single institution experience over ten years". British Journal of Haematology. 152 (6): 766–770. doi:10.1111/j.1365-2141.2010.08451.x. PMID 21275951. S2CID 44562296.
Gyang E, Yeom K, Hoppe C, Partap S, Jeng M (January 2011). "Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease". American Journal of Hematology. 86 (1): 104–106. doi:10.1002/ajh.21901. PMID 21117059.
Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, et al. (March 2010). "Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease". European Journal of Haematology. 84 (3): 259–265. doi:10.1111/j.1600-0609.2009.01379.x. PMID 19912310. S2CID 24316310.
Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, et al. (August 1996). "Bone marrow transplantation for sickle cell disease". The New England Journal of Medicine. 335 (6): 369–376. doi:10.1056/NEJM199608083350601. PMID 8663884. S2CID 25256772.
Callaway D, Chawla A, Sprinz P (November 2020). "Physical Therapy in Pediatric and Young Adult Patients With Sickle Cell Disease: Assessing Potential Benefits and Barriers". Journal of Pediatric Hematology/Oncology. 42 (8): 463–466. doi:10.1097/MPH.0000000000001888. ISSN 1536-3678. PMID 32815878.
Zanoni CT, Galvão F, Maria RM, Zulli R, Ricciardi JB, Cliquet a J, et al. (2020). "Effectiveness of a home-based therapeutic exercise program on lower back pain and functionality in Sickle Cell Disease (SCD) patients". Hematology, Transfusion and Cell Therapy. 43 (3): 268–279. doi:10.1016/j.htct.2020.05.004. PMC 8446254. PMID 32680757.
Wierenga KJ, Hambleton IR, Lewis NA (March 2001). "Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study". Lancet. 357 (9257): 680–683. doi:10.1016/s0140-6736(00)04132-5. PMID 11247552. S2CID 37012133.
Prabhakar H, Haywood C, Molokie R (May 2010). "Sickle cell disease in the United States: looking back and forward at 100 years of progress in management and survival". American Journal of Hematology. 85 (5): 346–353. doi:10.1002/ajh.21676. PMID 20425797.
Weatherall DJ, Clegg JB (2001). "Inherited haemoglobin disorders: an increasing global health problem". Bulletin of the World Health Organization. 79 (8): 704–712. PMC 2566499. PMID 11545326.
Roberts I, de Montalembert M (July 2007). "Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe". Haematologica. 92 (7): 865–871. doi:10.3324/haematol.11474. PMID 17606434.
Wellems TE, Hayton K, Fairhurst RM (September 2009). "The impact of malaria parasitism: from corpuscles to communities". The Journal of Clinical Investigation. 119 (9): 2496–2505. doi:10.1172/JCI38307. PMC 2735907. PMID 19729847.
Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, et al. (April 2002). "Protective effects of the sickle cell gene against malaria morbidity and mortality". Lancet. 359 (9314): 1311–1312. doi:10.1016/S0140-6736(02)08273-9. PMID 11965279. S2CID 37952036.
Tusuubira SK, Nakayinga R, Mwambi B, Odda J, Kiconco S, Komuhangi A (April 2018). "Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda". BMC Public Health. 18 (1): 561. doi:10.1186/s12889-018-5496-4. PMC 5924488. PMID 29703184.
Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, et al. (March 2016). "Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study". The Lancet. Global Health. 4 (3): e195–e200. doi:10.1016/S2214-109X(15)00288-0. PMID 26833239.
Edwards QT, Seibert D, Macri C, Covington C, Tilghman J (November 2004). "Assessing ethnicity in preconception counseling: genetics—what nurse practitioners need to know". Journal of the American Academy of Nurse Practitioners. 16 (11): 472–480. doi:10.1111/j.1745-7599.2004.tb00426.x. PMID 15617360. S2CID 7644129.
Vlachadis N, Vrachnis N (15 November 2022). "A Review of Sickle Cell Disease". JAMA. 328 (19): 1979. doi:10.1001/jama.2022.16732. ISSN 0098-7484. PMID 36378213.
Bardakdjian J, Wajcman H (September 2004). "[Epidemiology of sickle cell anemia]". La Revue du Praticien (in French). 54 (14): 1531–1533. PMID 15558961.
Beillat M, Durand-Zaleski I, Pirenne F, Bénard S, Chillotti L, Galacteros F (21 September 2023). "Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires". Frontiers in Public Health. 11: 1215605. doi:10.3389/fpubh.2023.1215605. PMC 10552641. PMID 37808997.
Thuret I, Sarles J, Merono F, Suzineau E, Collomb J, Lena-Russo D, et al. (June 2010). "Neonatal screening for sickle cell disease in France: evaluation of the selective process". Journal of Clinical Pathology. 63 (6): 548–551. doi:10.1136/jcp.2009.068874. PMID 20498028. S2CID 22391674.
Jastaniah W (2011). "Epidemiology of sickle cell disease in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 289–293. doi:10.4103/0256-4947.81540. PMC 3119971. PMID 21623060.
Memish ZA, Saeedi MY (2011). "Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 229–235. doi:10.4103/0256-4947.81527. PMC 3119961. PMID 21623050.
Al Arrayed S, Al Hajeri A (2010). "Public awareness of sickle cell disease in Bahrain". Annals of Saudi Medicine. 30 (4): 284–288. doi:10.4103/0256-4947.65256. PMC 2931779. PMID 20622345.
Asnani MR, McCaw-Binns AM, Reid ME (2011). "Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007". PLOS ONE. 6 (10): e26281. Bibcode:2011PLoSO...626281A. doi:10.1371/journal.pone.0026281. PMC 3200316. PMID 22039456.
Ballas SK, Gupta K, Adams-Graves P (November 2012). "Sickle cell pain: a critical reappraisal". Blood. 120 (18): 3647–3656. doi:10.1182/blood-2012-04-383430. PMID 22923496.
Herrick JB (1 November 1910). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia". Archives of Internal Medicine. 6 (5): 179–184. doi:10.1001/archinte.1910.00050330050003.; reprinted as Herrick JB (2001). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910". The Yale Journal of Biology and Medicine. 74 (3): 179–184. PMC 2588723. PMID 11501714.
Mason VR (1922). "Sickle cell anemia". The Journal of the American Medical Association. 79 (16): 1318–1320. doi:10.1001/jama.1922.02640160038012. Reprinted in Mason VR (October 1985). "Landmark article Oct. 14, 1922: Sickle cell anemia. By V.R. Mason". The Journal of the American Medical Association. 254 (14): 1955–1957. doi:10.1001/jama.254.14.1955. PMID 3900438.
Pauling L, Itano HA (November 1949). "Sickle cell anemia a molecular disease". Science. 110 (2865): 543–548. Bibcode:1949Sci...110..543P. doi:10.1126/science.110.2865.543. PMID 15395398. S2CID 31674765.
Ingram VM (October 1956). "A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin". Nature. 178 (4537): 792–794. Bibcode:1956Natur.178..792I. doi:10.1038/178792a0. PMID 13369537. S2CID 4167855.
Richard-Lenoble D, Toublanc JE, Zinsou RD, Kombila M, Carme B (1980). "[Results of a systematic study of drepanocytosis in 1,500 Gabonese using hemoglobin electrophoresis]" [Results of a systematic study of drepanocytosis in 1,500 Gabonese using hemoglobin electrophoresis]. Bulletin de la Société de Pathologie Exotique et de ses Filiales (in French). 73 (2): 200–206. PMID 7460122.
Srikanthan S (2023). "Contested Disability: Sickle Cell Disease". Health & Social Work. 48 (3): 209–216. doi:10.1093/hsw/hlad014. PMID 37315205.
Bulgin D, Tanabe P, Jenerette C (August 2018). "Stigma of Sickle Cell Disease: A Systematic Review". Issues in Mental Health Nursing. 39 (8): 675–686. doi:10.1080/01612840.2018.1443530. PMC 6186193. PMID 29652215.
Tusuubira SK, Naggawa T, Nakamoga V (October 2019). "To Join Or Not To Join? A Case Of Sickle Cell Clubs, Stigma And Discrimination In Secondary Schools In Butambala District, Uganda". Adolescent Health, Medicine and Therapeutics. 10: 145–152. doi:10.2147/AHMT.S223956. PMC 6778728. PMID 31632168.
Tusuubira SK, Nakayinga R, Mwambi B, Odda J, Kiconco S, Komuhangi A (April 2018). "Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda". BMC Public Health. 18 (1): 561. doi:10.1186/s12889-018-5496-4. PMC 5924488. PMID 29703184.
Okwi AL, Byarugaba W, Ndugwa CM, Parkes A, Ocaido M, Tumwine JK (September 2009). "Knowledge gaps, attitude and beliefs of the communities about sickle cell disease in Eastern and Western Uganda". East African Medical Journal. 86 (9): 442–449. doi:10.4314/eamj.v86i9.54167. PMID 21644415.
Marsh VM, Kamuya DM, Molyneux SS (August 2011). "'All her children are born that way': gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya". Ethnicity & Health. 16 (4–5): 343–359. doi:10.1080/13557858.2010.541903. PMC 3534410. PMID 21797722.
Sehlo MG, Kamfar HZ (April 2015). "Depression and quality of life in children with sickle cell disease: the effect of social support". BMC Psychiatry. 15 (1): 78. doi:10.1186/s12888-015-0461-6. PMC 4394397. PMID 25880537.
Kassim AA, Sharma D (December 2017). "Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape". Hematology/Oncology and Stem Cell Therapy. 10 (4): 259–266. doi:10.1016/j.hemonc.2017.05.008. PMID 28641096.
Olowoyeye A, Okwundu CI (November 2020). "Gene therapy for sickle cell disease". The Cochrane Database of Systematic Reviews. 2020 (11): CD007652. doi:10.1002/14651858.CD007652.pub7. PMC 8275984. PMID 33251574.
Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, et al. (December 2001). "Correction of sickle cell disease in transgenic mouse models by gene therapy". Science. 294 (5550): 2368–2371. Bibcode:2001Sci...294.2368P. doi:10.1126/science.1065806. PMID 11743206. S2CID 25607771.
Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. (March 2017). "Gene Therapy in a Patient with Sickle Cell Disease". The New England Journal of Medicine. 376 (9): 848–855. doi:10.1056/NEJMoa1609677. PMID 28249145. S2CID 5128871.
Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, et al. (November 2016). "CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells". Nature. 539 (7629): 384–389. Bibcode:2016Natur.539..384D. doi:10.1038/nature20134. PMC 5898607. PMID 27820943.
Zipkin M (6 December 2019). "CRISPR's "magnificent moment" in the clinic". Nature Biotechnology. doi:10.1038/d41587-019-00035-2. PMID 33277639. S2CID 213060203.
Persaud A, Desine S, Blizinsky K, Bonham VL (August 2019). "A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease community". Genetics in Medicine. 21 (8): 1726–1734. doi:10.1038/s41436-018-0409-6. PMC 6606394. PMID 30581191.
Oringanje C, Nemecek E, Oniyangi O (July 2020). "Hematopoietic stem cell transplantation for people with sickle cell disease". The Cochrane Database of Systematic Reviews. 2020 (7): CD007001. doi:10.1002/14651858.CD007001.pub5. PMC 7390490. PMID 32617981.

ncbi.nlm.nih.gov

Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (Global Burden of Disease Study 2013 Collaborators) (August 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 386 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472.
Anie KA, Green J (May 2015). "Psychological therapies for sickle cell disease and pain". The Cochrane Database of Systematic Reviews. 2015 (5): CD001916. doi:10.1002/14651858.CD001916.pub3. PMC 7063720. PMID 25966336.
Sysol JR, Machado R (2016). "Sickle Cell Disease and Acute Chest Syndrome: Epidemiology, Diagnosis, Management, Outcomes". Hematologic Abnormalities and Acute Lung Syndromes. Respiratory Medicine. pp. 67–87. doi:10.1007/978-3-319-41912-1_4. ISBN 978-3-319-41910-7. PMC 7120070.
Jadavji T, Prober CG (April 1985). "Dactylitis in a child with sickle cell trait". Canadian Medical Association Journal. 132 (7): 814–815. PMC 1345873. PMID 3978504.
Friend A, Girzadas D (2021). "Acute Chest Syndrome". StatPearls. StatPearls Publishing. PMID 28722902. Retrieved 21 March 2021.
Martí-Carvajal AJ, Solà I, Agreda-Pérez LH (December 2019). "Treatment for avascular necrosis of bone in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 2019 (12): CD004344. doi:10.1002/14651858.CD004344.pub7. PMC 6894369. PMID 31803937.
Kenny MW, George AJ, Stuart J (July 1980). "Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism". Journal of Clinical Pathology. 33 (7): 622–625. doi:10.1136/jcp.33.7.622. PMC 1146172. PMID 7430367.
Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT (June 2014). "Pulmonary arterial hypertension: the clinical syndrome". Circulation Research. 115 (1): 115–130. doi:10.1161/CIRCRESAHA.115.301146. PMC 4096686. PMID 24951762.
Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, et al. (March 2016). "Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease". JACC. Cardiovascular Imaging. 9 (3): 243–252. doi:10.1016/j.jcmg.2015.05.013. PMC 4788530. PMID 26897687.
Niss O, Fleck R, Makue F, Alsaied T, Desai P, Towbin JA, et al. (July 2017). "Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia". Blood. 130 (2): 205–213. doi:10.1182/blood-2017-02-767624. PMC 5510791. PMID 28507082.
Sankaran VG, Orkin SH (January 2013). "The switch from fetal to adult hemoglobin". Cold Spring Harbor Perspectives in Medicine. 3 (1): a011643. doi:10.1101/cshperspect.a011643. PMC 3530042. PMID 23209159.
Odièvre MH, Verger E, Silva-Pinto AC, Elion J (October 2011). "Pathophysiological insights in sickle cell disease". The Indian Journal of Medical Research. 134 (1): 532–537. doi:10.1007/bf00168807. PMC 3237253. PMID 22089617.
Kwiatkowski DP (August 2005). "How malaria has affected the human genome and what human genetics can teach us about malaria". American Journal of Human Genetics. 77 (2): 171–192. doi:10.1086/432519. PMC 1224522. PMID 16001361.
Ponçon N, Toty C, L'Ambert G, Le Goff G, Brengues C, Schaffner F, et al. (February 2007). "Biology and dynamics of potential malaria vectors in Southern France". Malaria Journal. 6 (1): 18. doi:10.1186/1475-2875-6-18. PMC 1808464. PMID 17313664.
Goldsmith JC, Bonham VL, Joiner CH, Kato GJ, Noonan AS, Steinberg MH (March 2012). "Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications". American Journal of Hematology. 87 (3): 340–346. doi:10.1002/ajh.22271. PMC 3513289. PMID 22307997.
Soe HH, Abas AB, Than NN, Ni H, Singh J, Said AR, et al. (May 2020). "Vitamin D supplementation for sickle cell disease". The Cochrane Database of Systematic Reviews. 5 (9): CD010858. doi:10.1002/14651858.CD010858.pub3. PMC 7386793. PMID 32462740.
Dixit R, Nettem S, Madan SS, Soe HH, Abas AB, Vance LD, et al. (March 2018). "Folate supplementation in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 3 (4): CD011130. doi:10.1002/14651858.CD011130.pub3. PMC 5440187. PMID 29546732.
Oniyangi O, Omari AA (November 2019). "Malaria chemoprophylaxis in sickle cell disease". The Cochrane Database of Systematic Reviews. 2019 (11). doi:10.1002/14651858.CD003489.pub2. PMC 6532723. PMID 31681984.
Okomo U, Meremikwu MM (July 2017). "Fluid replacement therapy for acute episodes of pain in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 7 (4): CD005406. doi:10.1002/14651858.CD005406.pub5. PMC 6483538. PMID 28759112.
Martí-Carvajal AJ, Conterno LO, Knight-Madden JM (September 2019). "Antibiotics for treating acute chest syndrome in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 9 (4): CD006110. doi:10.1002/14651858.CD006110.pub5. PMC 6749554. PMID 31531967.
Dolatkhah R, Dastgiri S (January 2020). "Blood transfusions for treating acute chest syndrome in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 1 (1): CD007843. doi:10.1002/14651858.CD007843.pub4. PMC 6984655. PMID 31942751.
Rankine-Mullings AE, Nevitt SJ (September 2022). "Hydroxyurea (hydroxycarbamide) for sickle cell disease". The Cochrane Database of Systematic Reviews. 2022 (10): CD002202. doi:10.1002/14651858.CD002202.pub3. PMC 9435593. PMID 36047926.
Zanoni CT, Galvão F, Maria RM, Zulli R, Ricciardi JB, Cliquet a J, et al. (2020). "Effectiveness of a home-based therapeutic exercise program on lower back pain and functionality in Sickle Cell Disease (SCD) patients". Hematology, Transfusion and Cell Therapy. 43 (3): 268–279. doi:10.1016/j.htct.2020.05.004. PMC 8446254. PMID 32680757.
Weatherall DJ, Clegg JB (2001). "Inherited haemoglobin disorders: an increasing global health problem". Bulletin of the World Health Organization. 79 (8): 704–712. PMC 2566499. PMID 11545326.
Wellems TE, Hayton K, Fairhurst RM (September 2009). "The impact of malaria parasitism: from corpuscles to communities". The Journal of Clinical Investigation. 119 (9): 2496–2505. doi:10.1172/JCI38307. PMC 2735907. PMID 19729847.
Tusuubira SK, Nakayinga R, Mwambi B, Odda J, Kiconco S, Komuhangi A (April 2018). "Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda". BMC Public Health. 18 (1): 561. doi:10.1186/s12889-018-5496-4. PMC 5924488. PMID 29703184.
Beillat M, Durand-Zaleski I, Pirenne F, Bénard S, Chillotti L, Galacteros F (21 September 2023). "Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires". Frontiers in Public Health. 11: 1215605. doi:10.3389/fpubh.2023.1215605. PMC 10552641. PMID 37808997.
Jastaniah W (2011). "Epidemiology of sickle cell disease in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 289–293. doi:10.4103/0256-4947.81540. PMC 3119971. PMID 21623060.
Memish ZA, Saeedi MY (2011). "Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 229–235. doi:10.4103/0256-4947.81527. PMC 3119961. PMID 21623050.
Al Arrayed S, Al Hajeri A (2010). "Public awareness of sickle cell disease in Bahrain". Annals of Saudi Medicine. 30 (4): 284–288. doi:10.4103/0256-4947.65256. PMC 2931779. PMID 20622345.
Asnani MR, McCaw-Binns AM, Reid ME (2011). "Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007". PLOS ONE. 6 (10): e26281. Bibcode:2011PLoSO...626281A. doi:10.1371/journal.pone.0026281. PMC 3200316. PMID 22039456.
Herrick JB (1 November 1910). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia". Archives of Internal Medicine. 6 (5): 179–184. doi:10.1001/archinte.1910.00050330050003.; reprinted as Herrick JB (2001). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910". The Yale Journal of Biology and Medicine. 74 (3): 179–184. PMC 2588723. PMID 11501714.
Bulgin D, Tanabe P, Jenerette C (August 2018). "Stigma of Sickle Cell Disease: A Systematic Review". Issues in Mental Health Nursing. 39 (8): 675–686. doi:10.1080/01612840.2018.1443530. PMC 6186193. PMID 29652215.
Tusuubira SK, Naggawa T, Nakamoga V (October 2019). "To Join Or Not To Join? A Case Of Sickle Cell Clubs, Stigma And Discrimination In Secondary Schools In Butambala District, Uganda". Adolescent Health, Medicine and Therapeutics. 10: 145–152. doi:10.2147/AHMT.S223956. PMC 6778728. PMID 31632168.
Tusuubira SK, Nakayinga R, Mwambi B, Odda J, Kiconco S, Komuhangi A (April 2018). "Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda". BMC Public Health. 18 (1): 561. doi:10.1186/s12889-018-5496-4. PMC 5924488. PMID 29703184.
Marsh VM, Kamuya DM, Molyneux SS (August 2011). "'All her children are born that way': gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya". Ethnicity & Health. 16 (4–5): 343–359. doi:10.1080/13557858.2010.541903. PMC 3534410. PMID 21797722.
Sehlo MG, Kamfar HZ (April 2015). "Depression and quality of life in children with sickle cell disease: the effect of social support". BMC Psychiatry. 15 (1): 78. doi:10.1186/s12888-015-0461-6. PMC 4394397. PMID 25880537.
Olowoyeye A, Okwundu CI (November 2020). "Gene therapy for sickle cell disease". The Cochrane Database of Systematic Reviews. 2020 (11): CD007652. doi:10.1002/14651858.CD007652.pub7. PMC 8275984. PMID 33251574.
Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, et al. (November 2016). "CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells". Nature. 539 (7629): 384–389. Bibcode:2016Natur.539..384D. doi:10.1038/nature20134. PMC 5898607. PMID 27820943.
Persaud A, Desine S, Blizinsky K, Bonham VL (August 2019). "A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease community". Genetics in Medicine. 21 (8): 1726–1734. doi:10.1038/s41436-018-0409-6. PMC 6606394. PMID 30581191.
Oringanje C, Nemecek E, Oniyangi O (July 2020). "Hematopoietic stem cell transplantation for people with sickle cell disease". The Cochrane Database of Systematic Reviews. 2020 (7): CD007001. doi:10.1002/14651858.CD007001.pub5. PMC 7390490. PMID 32617981.

nhlbi.nih.gov

"What Are the Signs and Symptoms of Sickle Cell Disease?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"What Is Sickle Cell Disease?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 6 March 2016. Retrieved 8 March 2016.
"What Causes Sickle Cell Disease?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 24 March 2016. Retrieved 8 March 2016.
"How Is Sickle Cell Disease Diagnosed?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"How Is Sickle Cell Disease Treated?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"Sickle Cell Disease - How Sickle Cell Disease May Affect Your Health". www.nhlbi.nih.gov. National Heart, Lung, and Blood Institute. 23 April 2024. Retrieved 25 July 2024.
"Sickle Cell Disease - Symptoms | NHLBI, NIH". www.nhlbi.nih.gov. 30 August 2023. Retrieved 22 March 2024.
"Evidence-Based Management of Sickle Cell Disease" (PDF). 2014. Retrieved 16 November 2017. twice-daily prophylactic penicillin beginning in early infancy and continuing through at least age 5
National Heart, Lung and Blood Institute. "Sickle cell anemia, key points". Archived from the original on 2 December 2010. Retrieved 27 November 2010.
"Sickle Cell Disease | National Heart, Lung, and Blood Institute (NHLBI)". www.nhlbi.nih.gov. Retrieved 4 July 2020.

nlm.nih.gov

Pearson HA (August 1977). "Sickle cell anemia and severe infections due to encapsulated bacteria" (Free full text). The Journal of Infectious Diseases. 136 (Suppl): S25–S30. doi:10.1093/infdis/136.Supplement.S25. PMID 330779. Archived from the original on 27 May 2016.

ghr.nlm.nih.gov

"sickle cell disease". Genetics Home Reference. Archived from the original on 15 May 2016. Retrieved 7 May 2016.

npr.org

Stallings E (27 July 2019). "Genetic Counselors Of Color Tackle Racial, Ethnic Disparities In Health Care". NPR. Retrieved 23 February 2021.
"Sickle Cell Patients Endure Discrimination, Poor Care And Shortened Lives". NPR.org. 4 November 2017. Retrieved 12 November 2017.
"In A 1st, Doctors In U.S. Use CRISPR Tool To Treat Patient With Genetic Disorder". NPR. Retrieved 31 July 2019.

nsgc.org

"National Society of Genetic Counselors : About Genetic Counselors". www.nsgc.org. Retrieved 24 February 2021.

nwlh.nhs.uk

sickle-thal.nwlh.nhs.uk

"Keeping Well with Sickle Cell Disease - Brent Sickle Cell & Thalassaemia Centre". www.sickle-thal.nwlh.nhs.uk. Archived from the original on 3 October 2019. Retrieved 4 October 2019.

nytimes.com

Kolata G (24 May 2021). "These Sisters With Sickle Cell Had Devastating, and Preventable, Strokes". The New York Times.
Kolata G (27 January 2019). "These Patients Had Sickle-Cell Disease. Experimental Therapies Might Have Cured Them". The New York Times. Retrieved 28 January 2019.

oup.com

academic.oup.com

Srikanthan S (2023). "Contested Disability: Sickle Cell Disease". Health & Social Work. 48 (3): 209–216. doi:10.1093/hsw/hlad014. PMID 37315205.

psu.edu

citeseerx.ist.psu.edu

Mekontso Dessap A, Leon R, Habibi A, Nzouakou R, Roudot-Thoraval F, Adnot S, et al. (March 2008). "Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease". American Journal of Respiratory and Critical Care Medicine. 177 (6): 646–653. CiteSeerX 10.1.1.504.790. doi:10.1164/rccm.200710-1606OC. PMID 18174543.
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. (January 2008). "Daily assessment of pain in adults with sickle cell disease". Annals of Internal Medicine. 148 (2): 94–101. CiteSeerX 10.1.1.690.5870. doi:10.7326/0003-4819-148-2-200801150-00004. PMID 18195334. S2CID 34924760.

rarediseases.org

"Sickle Cell Disease". NORD (National Organization for Rare Disorders). Retrieved 10 June 2019.

science.org

Kaiser J (5 December 2020). "CRISPR and another genetic strategy fix cell defects in two common blood disorders". ScienceMag.org. Science. Retrieved 7 December 2020. ... teams report that two strategies for directly fixing malfunctioning blood cells have dramatically improved the health of a handful of people with these genetic diseases.

sciencedaily.com

St. Jude Children's Research Hospital (4 December 2008). "Gene Therapy Corrects Sickle Cell Disease In Laboratory Study". ScienceDaily. Archived from the original on 13 December 2014. Retrieved 17 December 2014.

screening.nhs.uk

sct.screening.nhs.uk

"Who is offered screening and when?". screening.nhs.uk. Archived from the original on 31 December 2014.

semanticscholar.org

api.semanticscholar.org

Wilkinson E (16 November 2023). "UK regulator approves "groundbreaking" gene treatment for sickle cell and β thalassaemia". BMJ. 383: 2706. doi:10.1136/bmj.p2706. ISSN 1756-1833. PMID 37973171. S2CID 265264939.
Rees DC, Williams TN, Gladwin MT (December 2010). "Sickle-cell disease". Lancet. 376 (9757): 2018–2031. doi:10.1016/s0140-6736(10)61029-x. PMID 21131035. S2CID 29909566.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. (September 2014). "Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members". The Journal of the American Medical Association. 312 (10): 1033–1048. doi:10.1001/jama.2014.10517. PMID 25203083. S2CID 37681044.
Wong WY, Powars DR, Chan L, Hiti A, Johnson C, Overturf G (March 1992). "Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience". American Journal of Hematology. 39 (3): 176–182. doi:10.1002/ajh.2830390305. PMID 1546714. S2CID 19977178.
Khatib R, Rabah R, Sarnaik SA (January 2009). "The spleen in the sickling disorders: an update". Pediatric Radiology. 39 (1): 17–22. doi:10.1007/s00247-008-1049-9. PMID 19002450. S2CID 2547649.
Paul RN, Castro OL, Aggarwal A, Oneal PA (September 2011). "Acute chest syndrome: sickle cell disease". European Journal of Haematology. 87 (3): 191–207. doi:10.1111/j.1600-0609.2011.01647.x. PMID 21615795. S2CID 40320701.
Miller ST (May 2011). "How I treat acute chest syndrome in children with sickle cell disease". Blood. 117 (20): 5297–5305. doi:10.1182/blood-2010-11-261834. PMID 21406723. S2CID 206896811.
Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ (December 2011). "Management of children with sickle cell disease: a comprehensive review of the literature". Pediatrics. 128 (6): e1552–e1574. doi:10.1542/peds.2010-3686. PMID 22123880. S2CID 14524078. Archived from the original on 4 March 2016.
Almeida A, Roberts I (May 2005). "Bone involvement in sickle cell disease". British Journal of Haematology. 129 (4): 482–490. doi:10.1111/j.1365-2141.2005.05476.x. PMID 15877730. S2CID 908481.
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. (January 2008). "Daily assessment of pain in adults with sickle cell disease". Annals of Internal Medicine. 148 (2): 94–101. CiteSeerX 10.1.1.690.5870. doi:10.7326/0003-4819-148-2-200801150-00004. PMID 18195334. S2CID 34924760.
Caughey MC, Poole C, Ataga KI, Hinderliter AL (August 2015). "Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review". British Journal of Haematology. 170 (3): 416–424. doi:10.1111/bjh.13447. PMID 25854714. S2CID 23920740.
Rai P, Niss O, Malik P (November 2017). "A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia". Pediatric Blood & Cancer. 64 (11): e26607. doi:10.1002/pbc.26607. PMID 28453224. S2CID 24444332.
Green NS, Fabry ME, Kaptue-Noche L, Nagel RL (October 1993). "Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia". American Journal of Hematology. 44 (2): 145–146. doi:10.1002/ajh.2830440214. PMID 7505527. S2CID 27341091.
Lesi FE, Bassey EE (July 1972). "Family study in sickle cell disease in Nigeria". Journal of Biosocial Science. 4 (3): 307–313. doi:10.1017/S0021932000008622. PMID 5041262. S2CID 41719342.
Acharya K, Benjamin HJ, Clayton EW, Ross LF (November 2011). "Attitudes and beliefs of sports medicine providers to sickle cell trait screening of student athletes". Clinical Journal of Sport Medicine. 21 (6): 480–485. doi:10.1097/JSM.0b013e31822e8634. PMID 21959797. S2CID 11404187.
Ferrari R, Parker LS, Grubs RE, Krishnamurti L (December 2015). "Sickle Cell Trait Screening of Collegiate Athletes: Ethical Reasons for Program Reform". Journal of Genetic Counseling. 24 (6): 873–877. doi:10.1007/s10897-015-9849-1. PMID 26040250. S2CID 15889144.
Martin C, Pialoux V, Faes C, Charrin E, Skinner S, Connes P (February 2018). "Does physical activity increase or decrease the risk of sickle cell disease complications?". British Journal of Sports Medicine. 52 (4): 214–218. doi:10.1136/bjsports-2015-095317. PMID 26701924. S2CID 24464344.
Carroll CP (January 2020). "Opioid treatment for acute and chronic pain in patients with sickle cell disease". Neuroscience Letters. 714. Elsevier BV: 134534. doi:10.1016/j.neulet.2019.134534. PMID 31593753. S2CID 203667575.
Platt OS (March 2008). "Hydroxyurea for the treatment of sickle cell anemia". The New England Journal of Medicine. 358 (13): 1362–1369. doi:10.1056/NEJMct0708272. PMID 18367739. S2CID 351061.
Drasar E, Igbineweka N, Vasavda N, Free M, Awogbade M, Allman M, et al. (March 2011). "Blood transfusion usage among adults with sickle cell disease – a single institution experience over ten years". British Journal of Haematology. 152 (6): 766–770. doi:10.1111/j.1365-2141.2010.08451.x. PMID 21275951. S2CID 44562296.
Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, et al. (March 2010). "Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease". European Journal of Haematology. 84 (3): 259–265. doi:10.1111/j.1600-0609.2009.01379.x. PMID 19912310. S2CID 24316310.
Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, et al. (August 1996). "Bone marrow transplantation for sickle cell disease". The New England Journal of Medicine. 335 (6): 369–376. doi:10.1056/NEJM199608083350601. PMID 8663884. S2CID 25256772.
Wierenga KJ, Hambleton IR, Lewis NA (March 2001). "Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study". Lancet. 357 (9257): 680–683. doi:10.1016/s0140-6736(00)04132-5. PMID 11247552. S2CID 37012133.
Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, et al. (April 2002). "Protective effects of the sickle cell gene against malaria morbidity and mortality". Lancet. 359 (9314): 1311–1312. doi:10.1016/S0140-6736(02)08273-9. PMID 11965279. S2CID 37952036.
Edwards QT, Seibert D, Macri C, Covington C, Tilghman J (November 2004). "Assessing ethnicity in preconception counseling: genetics—what nurse practitioners need to know". Journal of the American Academy of Nurse Practitioners. 16 (11): 472–480. doi:10.1111/j.1745-7599.2004.tb00426.x. PMID 15617360. S2CID 7644129.
Thuret I, Sarles J, Merono F, Suzineau E, Collomb J, Lena-Russo D, et al. (June 2010). "Neonatal screening for sickle cell disease in France: evaluation of the selective process". Journal of Clinical Pathology. 63 (6): 548–551. doi:10.1136/jcp.2009.068874. PMID 20498028. S2CID 22391674.
Pauling L, Itano HA (November 1949). "Sickle cell anemia a molecular disease". Science. 110 (2865): 543–548. Bibcode:1949Sci...110..543P. doi:10.1126/science.110.2865.543. PMID 15395398. S2CID 31674765.
Ingram VM (October 1956). "A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin". Nature. 178 (4537): 792–794. Bibcode:1956Natur.178..792I. doi:10.1038/178792a0. PMID 13369537. S2CID 4167855.
Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, et al. (December 2001). "Correction of sickle cell disease in transgenic mouse models by gene therapy". Science. 294 (5550): 2368–2371. Bibcode:2001Sci...294.2368P. doi:10.1126/science.1065806. PMID 11743206. S2CID 25607771.
Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. (March 2017). "Gene Therapy in a Patient with Sickle Cell Disease". The New England Journal of Medicine. 376 (9): 848–855. doi:10.1056/NEJMoa1609677. PMID 28249145. S2CID 5128871.
Zipkin M (6 December 2019). "CRISPR's "magnificent moment" in the clinic". Nature Biotechnology. doi:10.1038/d41587-019-00035-2. PMID 33277639. S2CID 213060203.

sicklecellanemianews.com

Walker M (15 January 2018). "Gene Therapy". Sickle Cell Disease News. Retrieved 14 March 2020.

sicklecellsociety.org

"Inheritance of Sickle Cell Anaemia". Sickle Cell Society. Archived from the original on 8 January 2024. Retrieved 8 January 2024.
"Why is Blood from Afro-Caribbean Donors Special?". sicklecellsociety.org. Archived from the original on 30 December 2014.
Rylatt A (7 October 2022). "No-one is Listening" (PDF).

sicklecelluganda.org

"Sickle Cell Association of Uganda". Sickle Cell Association of Uganda. Retrieved 7 April 2021.

ssa.gov

"Social Security Ruling: SSR 2017-3p". U.S. Social Security Administration. Retrieved 15 January 2018.

stanfordchildrens.org

"default – Stanford Children's Health". www.stanfordchildrens.org. Retrieved 14 March 2020.

the-scientist.com

Wilson JF (18 March 2002). "Murine Gene Therapy Corrects Symptoms of Sickle Cell Disease". The Scientist – Magazine of the Life Sciences. Retrieved 17 December 2014.

uscrfuganda.org

"Our Vision and Mission – Uganda Sickle Cell Rescue Foundation". 13 May 2017. Retrieved 6 April 2021.
"Background – Uganda Sickle Cell Rescue Foundation". 13 May 2017. Retrieved 6 April 2021.

virginia.edu

exhibits.hsl.virginia.edu

"UVa Hospital Celebrating 100 Years". University of Virginia. Archived from the original on 31 January 2015. Retrieved 28 January 2015.

voice-online.co.uk

"Better protection and support for people with sickle cell disease". The Voice. October 2022. pp. 16–17. Retrieved 7 October 2022.

web.archive.org

"What Are the Signs and Symptoms of Sickle Cell Disease?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"What Is Sickle Cell Disease?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 6 March 2016. Retrieved 8 March 2016.
"What Causes Sickle Cell Disease?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 24 March 2016. Retrieved 8 March 2016.
"How Is Sickle Cell Disease Diagnosed?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"Sickle-cell disease and other haemoglobin disorders Fact sheet N°308". January 2011. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"How Is Sickle Cell Disease Treated?". National Heart, Lung, and Blood Institute. 12 June 2015. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"Learning About Sickle Cell Disease". National Human Genome Research Institute. 9 May 2016. Archived from the original on 4 January 2017. Retrieved 23 January 2017.
"FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease". U.S. Food and Drug Administration (FDA). 8 December 2023. Archived from the original on 8 December 2023. Retrieved 8 December 2023. This article incorporates text from this source, which is in the public domain.
"BestBets: How long should an average sickle cell crisis last?". Archived from the original on 17 June 2010. Retrieved 27 November 2010.
Pearson HA (August 1977). "Sickle cell anemia and severe infections due to encapsulated bacteria" (Free full text). The Journal of Infectious Diseases. 136 (Suppl): S25–S30. doi:10.1093/infdis/136.Supplement.S25. PMID 330779. Archived from the original on 27 May 2016.
Worrall VT, Butera V (December 1976). "Sickle-cell dactylitis". The Journal of Bone and Joint Surgery. American Volume. 58 (8): 1161–1163. doi:10.2106/00004623-197658080-00024. PMID 1002763. Archived from the original on 23 September 2016.
Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ (December 2011). "Management of children with sickle cell disease: a comprehensive review of the literature". Pediatrics. 128 (6): e1552–e1574. doi:10.1542/peds.2010-3686. PMID 22123880. S2CID 14524078. Archived from the original on 4 March 2016.
"sickle cell disease". Genetics Home Reference. Archived from the original on 15 May 2016. Retrieved 7 May 2016.
"Inheritance of Sickle Cell Anaemia". Sickle Cell Society. Archived from the original on 8 January 2024. Retrieved 8 January 2024.
"How Does Sickle Cell Cause Disease?". Archived from the original on 23 September 2010. Retrieved 27 November 2010.
"Sickle Cell Anemia: eMedicine Emergency Medicine". Archived from the original on 4 December 2010. Retrieved 27 November 2010.
Clarke GM, Higgins TN (August 2000). "Laboratory investigation of hemoglobinopathies and thalassemias: review and update". Clinical Chemistry. 46 (8 Pt 2): 1284–1290. doi:10.1093/clinchem/46.8.1284. PMID 10926923. Archived from the original on 20 March 2008.
"BestBets: Does routine urinalysis and chest radiography detect occult bacterial infection in sickle cell patients presenting to the accident and emergency department with painful crisis?". Archived from the original on 17 June 2010. Retrieved 27 November 2010.
"ABGC – Information for Certified Genetic Counselors | ABGC". www.abgc.net. Archived from the original on 19 April 2021. Retrieved 23 February 2021.
"Statement on Screening for Sickle Cell Trait and Athletic Participation". American Society of Hematology. Archived from the original on 26 January 2021. Retrieved 24 February 2021.
"Keeping Well with Sickle Cell Disease - Brent Sickle Cell & Thalassaemia Centre". www.sickle-thal.nwlh.nhs.uk. Archived from the original on 3 October 2019. Retrieved 4 October 2019.
"Nutrition for the Child with Sickle Cell Anemia". www.eatright.org. Archived from the original on 19 June 2020. Retrieved 5 October 2019.
Office of the Commissioner (7 July 2017). "Press Announcements – FDA approves new treatment for sickle cell disease". www.fda.gov. Archived from the original on 10 July 2017. Retrieved 10 July 2017.
"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". Medicines and Healthcare products Regulatory Agency (MHRA) (Press release). 16 November 2023. Archived from the original on 25 November 2023. Retrieved 8 December 2023.
WHO. "Sickle-cell anaemia – Report by the Secretariat" (PDF). Archived from the original (PDF) on 4 January 2011. Retrieved 27 November 2010.
National Heart, Lung and Blood Institute. "Sickle cell anemia, key points". Archived from the original on 2 December 2010. Retrieved 27 November 2010.
"September is Sickle Cell Awareness Month". CDC. Archived from the original on 27 September 2010. Retrieved 6 February 2011.
"Disorder Name: Sickle Cell Disease". New Born Screening. Archived from the original on 28 September 2016. Retrieved 11 October 2016.
"Inheriting sickle cell anaemia – Live Well – NHS Choices". www.nhs.uk. 23 October 2017. Archived from the original on 2 December 2014.
"Sickle cell anaemia – NHS Choices". www.nhs.uk. 23 October 2017. Archived from the original on 13 December 2011.
"Who is offered screening and when?". screening.nhs.uk. Archived from the original on 31 December 2014.
"Give Blood – Resources – Sickle Cell and Blood Donation". Give Blood. Archived from the original on 31 December 2014.
"Why is Blood from Afro-Caribbean Donors Special?". sicklecellsociety.org. Archived from the original on 30 December 2014.
Al Arrayed S (1995). "Features of sickle-cell disease in Bahrain". Eastern Mediterranean Health Journal. 1 (1). Archived from the original on 8 October 2016.
"Sickle Cell Anemia". American Society of Hematology. 16 December 2014. Archived from the original on 25 June 2017. Retrieved 1 May 2017.
"Life with sickle cell – Nation – Nepali Times". Archived from the original on 24 June 2015.
"UVa Hospital Celebrating 100 Years". University of Virginia. Archived from the original on 31 January 2015. Retrieved 28 January 2015.
"Foster, Gloria". Facts On File History Database. Archived from the original on 5 March 2016. Retrieved 25 February 2015.
St. Jude Children's Research Hospital (4 December 2008). "Gene Therapy Corrects Sickle Cell Disease In Laboratory Study". ScienceDaily. Archived from the original on 13 December 2014. Retrieved 17 December 2014.

who.int

"Sickle-cell disease and other haemoglobin disorders Fact sheet N°308". January 2011. Archived from the original on 9 March 2016. Retrieved 8 March 2016.

apps.who.int

WHO. "Sickle-cell anaemia – Report by the Secretariat" (PDF). Archived from the original (PDF) on 4 January 2011. Retrieved 27 November 2010.

emro.who.int

Al Arrayed S (1995). "Features of sickle-cell disease in Bahrain". Eastern Mediterranean Health Journal. 1 (1). Archived from the original on 8 October 2016.

worldcat.org

search.worldcat.org

Nelson MD, Bennett DM, Lehman ME, Okonji AI (5 December 2022). "Dizziness, Falls, and Hearing Loss in Adults Living With Sickle Cell Disease". American Journal of Audiology. 31 (4): 1178–1190. doi:10.1044/2022_AJA-22-00059. ISSN 1558-9137. PMID 36251873.
Wilkinson E (16 November 2023). "UK regulator approves "groundbreaking" gene treatment for sickle cell and β thalassaemia". BMJ. 383: 2706. doi:10.1136/bmj.p2706. ISSN 1756-1833. PMID 37973171. S2CID 265264939.
Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. (15 July 1995). "Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease [see comments]". Blood. 86 (2): 776–783. doi:10.1182/blood.v86.2.776.bloodjournal862776. ISSN 0006-4971.
Capriotti T, Frizzell JP (2016). Pathophysiology : introductory concepts and clinical perspectives. Philadelphia: F.A. Davis Company. ISBN 9780803615717. OCLC 900626405.
Callaway D, Chawla A, Sprinz P (November 2020). "Physical Therapy in Pediatric and Young Adult Patients With Sickle Cell Disease: Assessing Potential Benefits and Barriers". Journal of Pediatric Hematology/Oncology. 42 (8): 463–466. doi:10.1097/MPH.0000000000001888. ISSN 1536-3678. PMID 32815878.
Vlachadis N, Vrachnis N (15 November 2022). "A Review of Sickle Cell Disease". JAMA. 328 (19): 1979. doi:10.1001/jama.2022.16732. ISSN 0098-7484. PMID 36378213.
Washington HA (2006). Medical apartheid : the dark history of medical experimentation on Black Americans from colonial times to the present (1st paperback ed.). New York: Harlem Moon. ISBN 978-0-7679-1547-2. OCLC 192050177.

zenodo.org

Mason VR (1922). "Sickle cell anemia". The Journal of the American Medical Association. 79 (16): 1318–1320. doi:10.1001/jama.1922.02640160038012. Reprinted in Mason VR (October 1985). "Landmark article Oct. 14, 1922: Sickle cell anemia. By V.R. Mason". The Journal of the American Medical Association. 254 (14): 1955–1957. doi:10.1001/jama.254.14.1955. PMID 3900438.